Relapse prevention in panic disorder with pharmacotherapy: where are we now?

D. Caldirola, A. Alciati, S. Dacco, W. Micieli, G. Perna

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1699-1711
Number of pages13
JournalExpert Opinion on Pharmacotherapy
Volume21
Issue number14
DOIs
Publication statusPublished - 21 Sep 2020

Keywords

  • antidepressants
  • anxiety
  • attacks
  • comorbidity
  • controlled-trial
  • discontinuation
  • epidemiology
  • follow-up
  • imipramine therapy
  • panic disorder
  • personalized medicine
  • pharmacotherapy
  • relapse
  • risk
  • selective serotonin reuptake inhibitors
  • treatment outcome
  • tricyclic antidepressive agents
  • venlafaxine
  • CONTROLLED-TRIAL
  • ATTACKS
  • FOLLOW-UP
  • COMORBIDITY
  • IMIPRAMINE THERAPY
  • Panic disorder
  • ANXIETY
  • RISK
  • DISCONTINUATION
  • EPIDEMIOLOGY

Cite this